Juan F. Bejar-Grau
Villejuif, 94805, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Efficacy and safety of immune checkpoint inhibitor rechallenge in cervical and endometrial cancer: a multi-center retrospective study (RICE study).
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 23, 2026
Changes in Cyclin E1 expression and CCNE1 amplification in high-grade ovarian carcinomas post-PARP inhibitor exposure.
Journal: British journal of cancer
Published: August 06, 2025
Predictive biomarkers of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer.
Journal: Therapeutic advances in medical oncology
Published: July 10, 2025
Molecular and clinical insights into early-onset endometrial cancer.
Journal: Trends in cancer
Published: December 20, 2024
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making.
Journal: Tumori
Published: June 13, 2024
Immune predictors of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer.
Journal: Journal for immunotherapy of cancer
Published: June 04, 2024
Immunotherapy in the treatment of advanced or recurrent endometrial cancer.
Journal: Clinical advances in hematology & oncology : H&O
Published: April 08, 2024
Phase I Trial of First-line Bintrafusp Alfa in Patients with Locally Advanced or Persistent/Recurrent/Metastatic Cervical Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 27, 2023
Advances in immunotherapy for cervical cancer.
Journal: Therapeutic advances in medical oncology
Published: November 20, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026